RUNX3 exerts tumor-suppressive role through inhibiting EXOSC4 expression
Related Experiment Video
Updated: Jun 23, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Nan Wang1, Xiaodan Miao1, Wenxin Lu1
1Department of Pathology, Xuzhou Medical University, Xuzhou, China.
Abstract:
Breast cancer severely affects women health. 70% of breast cancer are estrogen receptor positive. Breast cancer stem cells are a group of tumor with plasticity, causing tumor relapse and metastasis. RUNX3 is a tumor suppressor frequently inactivated in estrogen receptor positive breast cancer. However, the mechanism of how RUNX3 is involved in the regualation of cancer stem cell traits in estrogen receptor positive breast cancer remains elusive. In this study, we utilized cut-tag assay to investigate the binding profile RUNX3 in BT474 and T47D cell, and confirmed EXOSC4 as the bona-fide target of RUNX3; RUNX3 could bind to the promoter are of EXOSC4 to suppress its expression. Furthermore, EXOSC4 could increase the colony formation, cell invasion and mammosphere formation ability of breast cancer cells and upregulate the the expression of SOX2 and ALDH1. Consistent with these findings, EXOSC4 was associated with poorer survival for Luminal B/Her2 breast cancer patiens. At last, we confirmed that EXOSC4 mediated the tumor suppressive role of RUNX3 in breast cancer cells. In conclusion, we demonstrate that RUNX3 directly binds to the promoter region of EXOSC4, leading to the suppression of EXOSC4 expression and exerting a tumor-suppressive effect in estrogen receptor postivive breast cancer cells.
Insights
RUNX3 suppresses estrogen receptor positive breast cancer by inhibiting EXOSC4 expression. This mechanism impacts cancer stem cell traits and patient survival, highlighting RUNX3
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Estrogen receptor-positive (ER+) breast cancer, prevalent in 70% of cases, is significantly impacted by cancer stem cells (CSCs) driving relapse and metastasis.
- RUNX3, a tumor suppressor, is frequently inactivated in ER+ breast cancer, but its role in regulating CSC traits remains unclear.
- Understanding RUNX3's regulatory mechanisms in ER+ breast cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the mechanism by which RUNX3 regulates cancer stem cell traits in estrogen receptor-positive breast cancer.
- To identify direct targets of RUNX3 involved in breast cancer progression.
- To investigate the functional role of EXOSC4 in breast cancer stemness and patient survival.
Main Methods:
- Utilized cut-and-tag assay in BT474 and T47D cells to determine RUNX3 binding profiles.
- Investigated the effect of EXOSC4 on breast cancer cell proliferation, invasion, and mammosphere formation.
- Analyzed the correlation between EXOSC4 expression and patient survival in Luminal B/Her2 breast cancer subtypes.
Main Results:
- Confirmed EXOSC4 as a direct transcriptional target of RUNX3, with RUNX3 binding to the EXOSC4 promoter to suppress its expression.
- Demonstrated that increased EXOSC4 expression enhances colony formation, invasion, and mammosphere formation, upregulating SOX2 and ALDH1.
- Found that higher EXOSC4 levels are associated with poorer survival in Luminal B/Her2 breast cancer patients, indicating its role in mediating RUNX3's tumor-suppressive function.
Conclusions:
- RUNX3 directly suppresses EXOSC4 expression by binding to its promoter region in ER+ breast cancer cells.
- EXOSC4 promotes breast cancer stemness and is linked to adverse patient outcomes, mediating the tumor-suppressive role of RUNX3.
- This study reveals a novel RUNX3-EXOSC4 axis critical for understanding and potentially targeting ER+ breast cancer progression.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
Inheritance of Chromatin Structures
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

